Lessons learned to enable question answering on knowledge graphs extracted from scientific publications: A case study on the coronavirus literature.

The article presents a workflow to create a question-answering system whose knowledge base combines knowledge graphs and scientific publications on coronaviruses. It is based on the experience gained in modeling evidence from research articles to provide answers to questions in natural language. The work contains best practices for acquiring scientific publications, tuning language models to identify and normalize relevant entities, creating representational models based on probabilistic topics, and formalizing an ontology that describes the associations between domain concepts supported by the scientific literature. All the resources generated in the domain of coronavirus are available openly as part of the Drugs4COVID initiative, and can be (re)-used independently or as a whole. They can be exploited by scientific communities conducting research related to SARS-CoV-2/COVID-19 and also by therapeutic communities, laboratories, etc., wishing to find and understand relationships between symptoms, drugs, active ingredients and their documentary evidence.

Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.

BACKGROUND: Drug-drug interactions (DDIs) that involve antiretrovirals (ARVs) tend to cause harm if unrecognized, especially in the context of comorbidity and polypharmacy. METHODS: A linkage was established between the drug dispensing registry of Madrid and the Liverpool human immunodeficiency virus (HIV) DDI database (January 2017-June 2017). Polypharmacy was defined as the use of ≥5 non-HIV medications, and DDIs were classified by a traffic-light ranking for severity. RESULTS: A total of 22 945 people living with HIV (PLWH) and 6 613 506 individuals without HIV had received medications. ARV regimens were predominantly based on integrase inhibitors (51.96%). Polypharmacy was higher in PLWH (32.94%) than individuals without HIV (22.16%; P < .001); this difference was consistently observed across all age strata except for individuals ≥75 years. Polypharmacy was more common in women than men in both PLWH and individuals without HIV. The prevalence of contraindicated combinations involving ARVs was 3.18%. Comedications containing corticosteroids, quetiapine, or antithrombotic agents were associated with the highest risk for red-flag DDI, and the use of raltegravir- or dolutegravir-based antiretroviral therapy was associated with an adjusted odds ratio of 0.72 (95% confidence interval, .60-.88; P = .001) for red-flag DDI. CONCLUSIONS: Polypharmacy was more frequent among PLWH across all age groups except those aged ≥75 years and was more common in women. The detection of contraindicated medications in PLWH suggests a likely disconnect between hospital and community prescriptions. Switching to alternative unboosted integrase regimens should be considered for patients with risk of harm from DDIs.